159 related articles for article (PubMed ID: 16856545)
1. [Antinociceptive effects of landiolol and esmolol].
Masaki E
Masui; 2006 Jul; 55(7):849-55. PubMed ID: 16856545
[TBL] [Abstract][Full Text] [Related]
2. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
Mio Y
Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
[TBL] [Abstract][Full Text] [Related]
3. The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.
Oda Y; Nishikawa K; Hase I; Asada A
Anesth Analg; 2005 Mar; 100(3):733-737. PubMed ID: 15728061
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of ultra-short-acting beta1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons.
Tanahashi S; Iida H; Dohi S; Oda A; Osawa Y; Yamaguchi S
Eur J Anaesthesiol; 2009 Mar; 26(3):196-200. PubMed ID: 19237982
[TBL] [Abstract][Full Text] [Related]
5. Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity.
Yamakage M; Iwasaki S; Jeong SW; Satoh J; Namiki A
Heart Lung; 2009; 38(1):48-55. PubMed ID: 19150530
[TBL] [Abstract][Full Text] [Related]
6. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.
Sasao J; Tarver SD; Kindscher JD; Taneyama C; Benson KT; Goto H
Can J Anaesth; 2001 Nov; 48(10):985-9. PubMed ID: 11698317
[TBL] [Abstract][Full Text] [Related]
7. Landiolol, a new ultra-short-acting beta1-blocker, reduces anaesthetic requirement during sevoflurane/N(2)O/fentanyl anaesthesia in surgical patients.
Tanabe T; Fukusaki M; Fujinaga A; Ando Y; Yamashita K; Terao Y; Sumikawa K
Eur J Anaesthesiol; 2009 Jan; 26(1):39-42. PubMed ID: 19122550
[TBL] [Abstract][Full Text] [Related]
8. Landiolol, an ultra short-acting beta1-adrenoceptor antagonist, does not alter the minimum alveolar anesthetic concentration of isoflurane in a swine model.
Kurita T; Takata K; Uraoka M; Morita K; Sato S
Anesth Analg; 2007 Sep; 105(3):656-60. PubMed ID: 17717219
[TBL] [Abstract][Full Text] [Related]
9. The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension.
Sugiura S; Seki S; Hidaka K; Masuoka M; Tsuchida H
Anesth Analg; 2007 Jan; 104(1):124-9. PubMed ID: 17179256
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of propofol, landiolol, and nicardipine on hemodynamic and bispectral index responses to endotracheal intubation: a prospective, randomized, double-blinded study.
Miyazaki M; Kadoi Y; Takashi S; Sawano Y; Shimada H
J Clin Anesth; 2008 Jun; 20(4):257-62. PubMed ID: 18617122
[TBL] [Abstract][Full Text] [Related]
11. Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.
Krumpl G; Ulc I; Trebs M; Kadlecová P; Hodisch J
Eur J Clin Pharmacol; 2017 Apr; 73(4):417-428. PubMed ID: 28091703
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.
Nasrollahi-Shirazi S; Sucic S; Yang Q; Freissmuth M; Nanoff C
J Pharmacol Exp Ther; 2016 Oct; 359(1):73-81. PubMed ID: 27451411
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.
Hirota K; Baba S; Fukushi S; Muraoka M; Matsuki A
J Anesth; 2005; 19(1):17-20. PubMed ID: 15674510
[TBL] [Abstract][Full Text] [Related]
14. [Effects of continuous infusion of landiolol on the hemodynamic response to tracheal intubation].
Onaka M; Yamamoto H
Masui; 2006 Feb; 55(2):174-8. PubMed ID: 16491894
[TBL] [Abstract][Full Text] [Related]
15. [Effects of landiolol on cardiovascular responses, bispectral index and body movement during endotracheal intubation].
Kawano T; Eguchi S; Iseki A; Oshita S
Masui; 2005 Jun; 54(6):610-4. PubMed ID: 15966376
[TBL] [Abstract][Full Text] [Related]
16. Effects of a short-acting [beta]1 receptor antagonist landiolol on hemodynamics and tissue injury markers in patients with subarachnoid hemorrhage undergoing intracranial aneurysm surgery.
Kawaguchi M; Utada K; Yoshitani K; Uchino H; Takeda Y; Masui K; Sakabe T;
J Neurosurg Anesthesiol; 2010 Jul; 22(3):230-9. PubMed ID: 20118792
[TBL] [Abstract][Full Text] [Related]
17. Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model.
Hagiwara S; Iwasaka H; Maeda H; Noguchi T
Shock; 2009 May; 31(5):515-20. PubMed ID: 18791493
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive and cardiovascular properties of esmolol following formalin injection in rats.
Davidson EM; Doursout MF; Szmuk P; Chelly JE
Can J Anaesth; 2001 Jan; 48(1):59-64. PubMed ID: 11212051
[TBL] [Abstract][Full Text] [Related]
19. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts.
Ikeshita K; Nishikawa K; Toriyama S; Yamashita T; Tani Y; Yamada T; Asada A
J Anesth; 2008; 22(4):361-6. PubMed ID: 19011773
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
Atarashi H; Kuruma A; Yashima M; Saitoh H; Ino T; Endoh Y; Hayakawa H
Clin Pharmacol Ther; 2000 Aug; 68(2):143-50. PubMed ID: 10976545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
